dr zafar semaglutide Dr. Muhammad Behzad Zafar, MD, Houston, TX Dr. Syed Zafar, MD, Douglasville, – Dr. Hammad Zafar, DPM, Phoenix,

Consuming large, high-fat meals shortly after starting Ozempic often precipitates or worsens nausea and abdominal discomfort due to delayed gastric emptying

Learn More Aesthetics & MedSpa Premium aesthetic treatments including Botox, fillers, PDO threads, and laser hair removal

p 9.5% Baseline characteristics Average age 54 years Average BMI - 36 Average weight - 220 lbs (100 kg) Type 2 diabetes - 58% Average NAFLD activity score - 5.3 Liver fibrosis stage: F2 - 43% | F3 - 57% Randomized treatment groups Group 1 (47 patients): Tirzepatide 5 mg once weekly Group 2 (47patients): Tirzepatide 10 mg once weekly Group 3 (48 patients): Tirzepatide 15 mg once weekly Group 4 (48 patients): Placebo Therapy was initiated at 2.5 mg, and patients were titrated to their assigned dose in 2.5 mg increments every 4 weeks Resolution of MASH (defined as no steatotic liver disease [steatosis score of 0] or simple steatosis [a steatosis score of 1, 2, or 3] without steatohepatitis and an inflammation score of 0 or 1 and a ballooning score of 0), without worsening of fibrosis (defined as no increase in the fibrosis stage) at week 52 Primary outcome: Results In this phase 2 trial involving participants with MASH and moderate or severe fibrosis, treatment with tirzepatide for 52 weeks was more effective than placebo with respect to resolution of MASH without worsening of fibrosis

Researchers sometimes compare this phenomenon to astronauts who experience bone loss in low-gravity environments